{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T11:55:00Z","timestamp":1771674900630,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,13]]},"DOI":"10.7759\/cureus.23127","type":"journal-article","created":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T17:04:15Z","timestamp":1647191055000},"source":"Crossref","is-referenced-by-count":8,"title":["Autoimmune Bullous Dermatosis Following COVID-19 Vaccination: A Series of Five Cases"],"prefix":"10.7759","author":[{"given":"Fouzia","family":"Hali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lamiae","family":"Araqi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farida","family":"Marnissi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahlam","family":"Meftah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soumiya","family":"Chiheb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2017.151","article-title":"Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction","volume":"15","author":"Segal Y","year":"2018","unstructured":"Segal Y, Shoenfeld Y. Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction. Cell Mol Immunol. 2018, 15:586-94. 10.1038\/cmi.2017.151","journal-title":"Cell Mol Immunol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.14238","article-title":"COVID-19 vaccination can occasionally trigger autoimmune phenomena, probably via inducing age-associated B cells","volume":"25","author":"Sachinidis A","year":"2022","unstructured":"Sachinidis A, Garyfallos A. COVID-19 vaccination can occasionally trigger autoimmune phenomena, probably via inducing age-associated B cells. Int J Rheum Dis. 2022, 25:83-5. 10.1111\/1756-185X.14238","journal-title":"Int J Rheum Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2019.09.004","article-title":"Pharmacovigilance\u00a0-\u00a0the next chapter","volume":"74","author":"Moore N","year":"2019","unstructured":"Moore N, Berda\u00ef D, Blin P, Droz C. Pharmacovigilance\u00a0-\u00a0the next chapter. Therapie. 2019, 74:557-67. 10.1016\/j.therap.2019.09.004","journal-title":"Therapie"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2021.01.007","article-title":"Impact of COVID-19 on autoimmune blistering diseases","volume":"39","author":"Drenovska K","year":"2021","unstructured":"Drenovska K, Vassileva S, Tanev I, Joly P. Impact of COVID-19 on autoimmune blistering diseases. Clin Dermatol. 2021, 39:359-68. 10.1016\/j.clindermatol.2021.01.007","journal-title":"Clin Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcli.2021.05.005","article-title":"Bullous pemphigoid and COVID-19 vaccine","volume":"157","author":"P\u00e9rez-L\u00f3pez I","year":"2021","unstructured":"P\u00e9rez-L\u00f3pez I, Moyano-Bueno D, Ruiz-Villaverde R. Bullous pemphigoid and COVID-19 vaccine. Med Clin (Barc). 2021, 157:e333-4. 10.1016\/j.medcli.2021.05.005","journal-title":"Med Clin (Barc)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/biom10101432","article-title":"Bullous pemphigoid: trigger and predisposing factors","volume":"10","author":"Moro F","year":"2020","unstructured":"Moro F, Fania L, Sinagra JL, Salemme A, Di Zenzo G. Bullous pemphigoid: trigger and predisposing factors. Biomolecules. 2020, 10:1432. 10.3390\/biom10101432","journal-title":"Biomolecules"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4103\/ijdvl.IJDVL_666_18","article-title":"Bullous pemphigoid triggered by rabies vaccine","volume":"86","author":"Jindal A","year":"2020","unstructured":"Jindal A, Nayak SU, Shenoi SD, Rao R, Monappa V. Bullous pemphigoid triggered by rabies vaccine. Indian J Dermatol Venereol Leprol. 2020, 86:66-8. 10.4103\/ijdvl.IJDVL_666_18","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s13312-016-0867-3","article-title":"Infantile bullous pemphigoid following vaccination","volume":"53","author":"Bisherwal K","year":"2016","unstructured":"Bisherwal K, Pandhi D, Singal A, Sharma S. Infantile bullous pemphigoid following vaccination. Indian Pediatr. 2016, 53:425-6. 10.1007\/s13312-016-0867-3","journal-title":"Indian Pediatr"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12366","article-title":"Drug-induced pemphigoid: a review of the literature","volume":"28","author":"Stavropoulos PG","year":"2014","unstructured":"Stavropoulos PG, Soura E, Antoniou C. Drug-induced pemphigoid: a review of the literature. J Eur Acad Dermatol Venereol. 2014, 28:1133-40. 10.1111\/jdv.12366","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1080\/08916930600971505","article-title":"Desmoglein autoimmunity in the pathogenesis of pemphigus","volume":"39","author":"Gniadecki R","year":"2006","unstructured":"Gniadecki R. Desmoglein autoimmunity in the pathogenesis of pemphigus. Autoimmunity. 2006, 39:541-7. 10.1080\/08916930600971505","journal-title":"Autoimmunity"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17472","article-title":"The first dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated?","volume":"35","author":"Damiani G","year":"2021","unstructured":"Damiani G, Pacifico A, Pelloni F, Iorizzo M. The first dose of COVID-19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated?. J Eur Acad Dermatol Venereol. 2021, 35:e645-7. 10.1111\/jdv.17472","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcpa.2007.04.013","article-title":"From tolerance to autoimmunity: is there a risk in early life vaccination?","volume":"137","author":"Goriely S","year":"2007","unstructured":"Goriely S, Goldman M. From tolerance to autoimmunity: is there a risk in early life vaccination?. J Comp Pathol. 2007, 137:S57-61. 10.1016\/j.jcpa.2007.04.013","journal-title":"J Comp Pathol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.807711","article-title":"Case report: circulating anti-SARS-CoV-2 antibodies do not cross-react with pemphigus or pemphigoid autoantigens","volume":"8","author":"Kasperkiewicz M","year":"2021","unstructured":"Kasperkiewicz M, Bednarek M, Tukaj S. Case report: circulating anti-SARS-CoV-2 antibodies do not cross-react with pemphigus or pemphigoid autoantigens. Front Med (Lausanne). 2021, 8:807711. 10.3389\/fmed.2021.807711","journal-title":"Front Med (Lausanne)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/89189-autoimmune-bullous-dermatosis-following-covid-19-vaccination-a-series-of-five-cases","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:41:35Z","timestamp":1707507695000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/89189-autoimmune-bullous-dermatosis-following-covid-19-vaccination-a-series-of-five-cases"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,13]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.23127","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,13]]}}}